Perseus Proteomics Inc. [4882.T]
TOKYO, Apr 01 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported the monthly exercise status for its convertible warrants issued on January 05, 2026.
In March 2026, the company delivered 1,200,000 shares based on the exercise of 850 warrants out of a total issuance of 2,000,000 warrants. On March 10, 2026, the warrant exercise price was adjusted to match the closing price of the stock on the day of issuance decision, which was December 17, 2025. As a result, the exercise rate exceeded the limit set by the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association's Rules on Third-Party Allotment Issues.
The overall exercise rate for March 2026 exceeded the permitted level of 13.22%. At the end of March, there were 1,135 unexercised warrants remaining, compared to 1,140 unexercised warrants at the end of February. The detailed information on the issuance of these warrants can be found in the press release dated December 17, 2025.
🟢 Confidence: High AI-translated content.